An adaptive randomized neoadjuvant two arm trial in triple-negative breast cancer (TNBC) comparing a mono Atezolizumab window followed by Atezolizumab - CTX therapy with Atezolizumab - CTX therapy (neoMono)

Autor:	J Rom, C Kolberg-Liedtke, Bernhard Heinrich, P Staib, HC Kolberg, Phaon scientific, H Forstbauer, O Hoffmann, M Braun, J Schumacher, Christian Schem
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Atezolizumab Internal medicine Medicine business Triple-negative breast cancer
Zdroj:	Senologie - Zeitschrift für Mammadiagnostik und -therapie.
ISSN:	1611-647X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0ccf090826dc1b5aae4b8c2860a8b71d https://doi.org/10.1055/s-0041-1730183 Zobrazit plný text záznamu